Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $51,052 | 32 | 98.0% |
| Food and Beverage | $621.78 | 28 | 1.2% |
| Travel and Lodging | $442.40 | 1 | 0.8% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Integra LifeSciences Corporation | $51,052 | 32 | $0 (2020) |
| Zimmer Biomet Holdings, Inc. | $672.20 | 11 | $0 (2023) |
| DePuy Synthes Sales Inc. | $187.41 | 10 | $0 (2019) |
| Pacira Pharmaceuticals Incorporated | $79.74 | 2 | $0 (2023) |
| MEDELA LLC | $45.00 | 1 | $0 (2020) |
| Ferring Pharmaceuticals Inc. | $32.51 | 2 | $0 (2018) |
| Ethicon US, LLC | $20.38 | 1 | $0 (2019) |
| DJO, LLC | $15.14 | 1 | $0 (2020) |
| ConvaTec Inc. | $11.80 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $488.56 | 4 | Zimmer Biomet Holdings, Inc. ($467.71) |
| 2022 | $145.88 | 6 | Zimmer Biomet Holdings, Inc. ($145.88) |
| 2020 | $22,832 | 19 | Integra LifeSciences Corporation ($22,760) |
| 2019 | $28,344 | 19 | Integra LifeSciences Corporation ($28,292) |
| 2018 | $242.93 | 10 | DePuy Synthes Sales Inc. ($92.92) |
| 2017 | $62.90 | 3 | DePuy Synthes Sales Inc. ($62.90) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/23/2023 | Zimmer Biomet Holdings, Inc. | ROSA (Device), Persona | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Knees | ||||||
| 03/22/2023 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Pain Management | ||||||
| 01/04/2023 | Zimmer Biomet Holdings, Inc. | ROSA (Device) | Travel and Lodging | In-kind items and services | $442.40 | General |
| Category: Knees | ||||||
| 01/04/2023 | Zimmer Biomet Holdings, Inc. | ROSA (Device) | Food and Beverage | In-kind items and services | $9.41 | General |
| Category: Knees | ||||||
| 08/19/2022 | Zimmer Biomet Holdings, Inc. | ROSA (Device) | Food and Beverage | In-kind items and services | $31.80 | General |
| Category: Knees | ||||||
| 08/19/2022 | Zimmer Biomet Holdings, Inc. | ROSA (Device) | Food and Beverage | In-kind items and services | $31.80 | General |
| Category: Knees | ||||||
| 08/19/2022 | Zimmer Biomet Holdings, Inc. | ROSA (Device) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: Knees | ||||||
| 08/19/2022 | Zimmer Biomet Holdings, Inc. | ROSA (Device) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: Knees | ||||||
| 08/19/2022 | Zimmer Biomet Holdings, Inc. | ROSA (Device) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Knees | ||||||
| 08/19/2022 | Zimmer Biomet Holdings, Inc. | ROSA (Device) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Knees | ||||||
| 10/20/2020 | MEDELA LLC | — | Food and Beverage | Cash or cash equivalent | $45.00 | General |
| Category: NPWT | ||||||
| 08/17/2020 | Integra LifeSciences Corporation | TITAN-SHOULDER (Device) | — | Cash or cash equivalent | $1,032.00 | Research |
| Study: CP-0960-001 • Category: RECON-UPPER EXTREMITY | ||||||
| 08/17/2020 | Integra LifeSciences Corporation | TITAN-SHOULDER (Device) | — | Cash or cash equivalent | $528.00 | Research |
| Study: T-TSS-002 • Category: RECON-UPPER EXTREMITY | ||||||
| 08/17/2020 | Integra LifeSciences Corporation | TITAN-SHOULDER (Device) | — | Cash or cash equivalent | $516.00 | Research |
| Study: CP-0960-001 • Category: RECON-UPPER EXTREMITY | ||||||
| 06/18/2020 | Integra LifeSciences Corporation | TITAN-SHOULDER (Device) | — | Cash or cash equivalent | $528.00 | Research |
| Study: T-TSS-002 • Category: RECON-UPPER EXTREMITY | ||||||
| 05/15/2020 | Integra LifeSciences Corporation | TITAN-SHOULDER (Device) | — | Cash or cash equivalent | $2,968.00 | Research |
| Study: CP-0960-001 • Category: RECON-UPPER EXTREMITY | ||||||
| 05/15/2020 | Integra LifeSciences Corporation | TITAN-SHOULDER (Device) | — | Cash or cash equivalent | $400.00 | Research |
| Study: T-TSS-002 • Category: RECON-UPPER EXTREMITY | ||||||
| 04/17/2020 | Integra LifeSciences Corporation | TITAN-SHOULDER (Device) | — | Cash or cash equivalent | $1,860.00 | Research |
| Study: CP-0960-001 • Category: RECON-UPPER EXTREMITY | ||||||
| 04/17/2020 | Integra LifeSciences Corporation | TITAN-SHOULDER (Device) | — | Cash or cash equivalent | $1,092.00 | Research |
| Study: T-TSS-002 • Category: RECON-UPPER EXTREMITY | ||||||
| 04/02/2020 | Integra LifeSciences Corporation | TITAN-SHOULDER (Device) | — | Cash or cash equivalent | $3,012.00 | Research |
| Study: T-TSS-002 • Category: RECON-UPPER EXTREMITY | ||||||
| 04/02/2020 | Integra LifeSciences Corporation | TITAN-SHOULDER (Device) | — | Cash or cash equivalent | $2,172.00 | Research |
| Study: CP-0960-001 • Category: RECON-UPPER EXTREMITY | ||||||
| 03/16/2020 | DJO, LLC | CMF OL1000 (Device) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Osteogenesis Stimulators | ||||||
| 02/21/2020 | Integra LifeSciences Corporation | TITAN-SHOULDER (Device) | — | Cash or cash equivalent | $1,920.00 | Research |
| Study: CP-0960-01 • Category: RECON-UPPER EXTREMITY | ||||||
| 02/21/2020 | Integra LifeSciences Corporation | TITAN-SHOULDER (Device) | — | Cash or cash equivalent | $1,896.00 | Research |
| Study: CP-0960-01 • Category: RECON-UPPER EXTREMITY | ||||||
| 02/12/2020 | ConvaTec Inc. | AQUACEL AG (Device), AVELLE | Food and Beverage | Cash or cash equivalent | $11.80 | General |
| Category: WOUND THERAPEUTICS | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| TSS-003 | Integra LifeSciences Corporation | $17,192 | 9 |
| CP-0960-001 | Integra LifeSciences Corporation | $13,012 | 7 |
| CP-0960-01 | Integra LifeSciences Corporation | $8,652 | 6 |
| T-TSS-002 | Integra LifeSciences Corporation | $5,560 | 5 |
| T-TSS-003 | Integra LifeSciences Corporation | $4,720 | 3 |
| IMV-2 | Integra LifeSciences Corporation | $1,516 | 1 |
| IMV-1 | Integra LifeSciences Corporation | $400.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 714 | 2,054 | $575,757 | $176,880 |
| 2022 | 19 | 1,490 | 3,494 | $934,673 | $301,392 |
| 2021 | 22 | 1,739 | 4,149 | $958,998 | $345,468 |
| 2020 | 17 | 1,647 | 4,365 | $800,716 | $287,306 |
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 27447 | Replacement of knee joint, both sides of knee | Facility | 2023 | 72 | 75 | $238,587 | $73,634 | 30.9% |
| 27130 | Replacement of thigh bone and hip joint with prosthesis | Facility | 2023 | 22 | 24 | $69,389 | $23,562 | 34.0% |
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | Office | 2023 | 22 | 42 | $82,352 | $23,266 | 28.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 67 | 75 | $22,686 | $9,415 | 41.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 111 | 128 | $19,192 | $8,098 | 42.2% |
| J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | Office | 2023 | 13 | 1,056 | $27,168 | $7,706 | 28.4% |
| J7326 | Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | Office | 2023 | 12 | 20 | $39,066 | $7,695 | 19.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 75 | $16,184 | $6,391 | 39.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 80 | 100 | $21,998 | $5,641 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $14,742 | $3,677 | 24.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 19 | 19 | $7,322 | $2,866 | 39.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 28 | 28 | $5,990 | $1,894 | 31.6% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 48 | 58 | $4,386 | $1,166 | 26.6% |
| 73560 | X-ray of knee, 1-2 views | Office | 2023 | 33 | 33 | $2,282 | $754.40 | 33.1% |
| 73502 | X-ray of hip, 2-3 views | Office | 2023 | 22 | 24 | $1,871 | $698.28 | 37.3% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 11 | 14 | $1,050 | $236.71 | 22.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 35 | 238 | $1,492 | $179.75 | 12.0% |
| 27447 | Replacement of knee joint, both sides of knee | Facility | 2022 | 71 | 74 | $301,698 | $72,310 | 24.0% |
| 27130 | Replacement of thigh bone and hip joint with prosthesis | Facility | 2022 | 49 | 50 | $170,750 | $48,704 | 28.5% |
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | Office | 2022 | 29 | 61 | $94,550 | $36,498 | 38.6% |
| J7326 | Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | Office | 2022 | 34 | 56 | $84,000 | $35,862 | 42.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 249 | 309 | $38,625 | $19,198 | 49.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 125 | 133 | $33,250 | $16,280 | 49.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 108 | 115 | $23,000 | $10,694 | 46.5% |
| J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | Office | 2022 | 17 | 1,344 | $33,600 | $10,644 | 31.7% |
About Dr. Thomas Westphal, M.D
Dr. Thomas Westphal, M.D is a Orthopaedic Surgery healthcare provider based in Lancaster, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083681621.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Westphal, M.D has received a total of $52,116 in payments from pharmaceutical and medical device companies, with $488.56 received in 2023. These payments were reported across 61 transactions from 9 companies. The most common payment nature is "" ($51,052).
As a Medicare-enrolled provider, Westphal has provided services to 5,590 Medicare beneficiaries, totaling 14,062 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Practice Information
- Specialty Orthopaedic Surgery
- Other Specialties Orthopaedic Surgery
- Location Lancaster, PA
- Active Since 03/02/2006
- Last Updated 04/27/2020
- Taxonomy Code 207X00000X
- Entity Type Individual
- NPI Number 1083681621
Products in Payments
- TITAN-SHOULDER (Device) $51,052
- ROSA (Device) $613.59
- MONOVISC (Device) $138.23
- EXPAREL (Drug) $58.89
- Persona (Device) $33.27
- EUFLEXXA (Device) $32.51
- INSTRUMENTS (Device) $27.79
- CORAIL (Device) $21.39
- Exparel (Drug) $20.85
- DERMABOND Portfolio (Device) $20.38
- CMF OL1000 (Device) $15.14
- AQUACEL AG (Device) $11.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Orthopaedic Surgery Doctors in Lancaster
Carl Becker, Md, MD
Orthopaedic Surgery — Payments: $366,431
Bradley Binsfeld, Do, DO
Orthopaedic Surgery — Payments: $206,975
Dr. Michael Bercik, M.d, M.D
Orthopaedic Surgery — Payments: $151,043
Dr. Mark D'onofrio, M.d, M.D
Orthopaedic Surgery — Payments: $106,832
Dr. Alan Tuckman, M.d, M.D
Orthopaedic Surgery — Payments: $95,511
Dr. Gary Zartman, Md, MD
Orthopaedic Surgery — Payments: $59,225